1Tavassoli FA, Devilee P. WHO classification af tumors. Pathology & genetic tumors of the breast and female genital organs [J]. Lyon IARC Presg, 2003, 10(5): 129.
2Weidner N. Current pathologic methods for measuring intratumoral mierovessel density within breast carcinoma and other solid tumors [J]. Breast Cancer Res Treat, 1995, 36: 169.
3Tanaka K, lwamoto S, Con G, et al. Expression of surviving and its relationship to loss of apotosis in breast carcinomas [J]. Clin Cancer Res, 2000, 6(1), 127-134.
4林毅,唐汉均.现代中医乳房病学[M].人民卫生出版社,2003:122-123.
5Folkman J. What is the evidence that turnouts are angiogenesis dependent[J]. J Natl Cancer Inst, 1990, 82: 4-6.
6Ottinetti A, Sapino A. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions [J]. Breast Cancer Res Treat, 1988, 11: 241-248.
7Fregene TA, Kellog C, Pienta KJ. Microvessel quantitation as a measure of angiogenic activity in benign breast tissues lesions: a marker for precancerous disease[J]. Int J Oncol 1994, 4: 1199- 1202.
8Guidi A, Fischer L, Harris J, et al. Microvessel density and distribution in ductal carcinomas in situ of the breast[J]. J Natl Cancer Inst, 1994, 86: 614-619.
9Engels K, Fox SB, Whitehouse RM, et al. Up-regulation of thymidine phosphorylase expression is associated with high-grade in situ ductal carcinomas of the breast[J]. J Pathol, 1997, 181: 207- 212.
